We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$822M
AUM Growth
-$41.1M
Cap. Flow
-$36.7M
Cap. Flow %
-4.46%
Top 10 Hldgs %
55.16%
Holding
88
New
20
Increased
19
Reduced
10
Closed
26

Top Buys

Rank Stock Value
1
UAA icon
Under Armour
UAA
+$22.1M
2
AVY icon
Avery Dennison
AVY
+$17.1M
3
HUM icon
Humana
HUM
+$14.3M
4
GNRC icon
Generac Holdings
GNRC
+$12.9M
5
RAPT
RAPT Therapeutics
RAPT
+$12.5M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$25.9M
2
AMD icon
Advanced Micro Devices
AMD
+$23.5M
3
CCK icon
Crown Holdings
CCK
+$22.2M
4
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$20.5M
5
VRT icon
Vertiv
VRT
+$18.3M

Sector Composition

Rank Sector Weight
1 Healthcare 24.26%
2 Consumer Discretionary 10.5%
3 Technology 9.81%
4 Communication Services 7.28%
5 Industrials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAPA
51
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$2.68M 0.33%
117,000
– –
PAGS icon
52
PUT
PagSeguro Digital
PAGS
$2.55B
$2.47M 0.3%
47,800
-137,200
-74% -$7.7M
EUCR
53
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$1.96M 0.24%
200,000
– –
FVRR icon
54
PUT
Fiverr
FVRR
$339M
$1.83M 0.22%
+10,000
New +$2.01M
NEXI
55
DELISTED
NexImmune, Inc. Common Stock
NEXI
$1.79M 0.22%
+4,718
New +$1.58M
APLS
56
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$1.65M 0.2%
+50,000
New +$2.81M
ACET icon
57
Adicet Bio
ACET
$74.7M
$1.1M 0.13%
8,750
+1,562
+22% +$194K
IFRX icon
58
InflaRx
IFRX
$271M
$1.04M 0.13%
400,000
– –
DNA icon
59
Ginkgo Bioworks
DNA
$521M
$869K 0.11%
+1,875
New +$913K
XCUR icon
60
Exicure
XCUR
$8.54M
$407K 0.05%
2,263
– –
EUCRW
61
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$48K 0.01%
66,665
– –
MSACW
62
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$22K ﹤0.01%
33,332
– –
AMD icon
63
Advanced Micro Devices
AMD
$789B
– –
-250,000
Closed -$23.5M
ARMK icon
64
Aramark
ARMK
$14.7B
– –
-552,615
Closed -$14.9M
AUPH icon
65
Aurinia Pharmaceuticals
AUPH
$2.11B
– –
-1,583,208
Closed -$20.5M
BIDU icon
66
Baidu
BIDU
$37.2B
– –
-84,000
Closed -$17.1M
BKR icon
67
Baker Hughes
BKR
$61.1B
– –
-408,000
Closed -$9.33M
CCK icon
68
Crown Holdings
CCK
$13.1B
– –
-217,312
Closed -$22.2M
CRC icon
69
California Resources
CRC
$4.62B
– –
-29,199
Closed -$880K
DHR icon
70
Danaher
DHR
$144B
– –
-48,625
Closed -$11.6M
DRIO icon
71
DarioHealth
DRIO
$71.2M
– –
-3,250
Closed -$1.39M
GOOGL icon
72
Alphabet (Google) Class A
GOOGL
$4.33T
– –
-99,840
Closed -$12.2M
GS icon
73
Goldman Sachs
GS
$303B
– –
-19,300
Closed -$7.33M
IGV icon
74
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$14.5B
– –
-250,000
Closed -$19.5M
MMYT icon
75
CALL
MakeMyTrip
MMYT
$5.64B
– –
-50,000
Closed -$1.5M
1 2
3
4

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Kingdon Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Kingdon Capital Management held 88 positions worth $822M, down 4.8% from $863M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Kingdon Capital Management withdrew a net $36.7M in Q3 2021, closing 26 positions and reducing 10 holdings. Its most notable exit was Advanced Micro Devices, an estimated $23.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Kingdon Capital Management opened a new position in Under Armour worth $20.2M.

  • Kingdon Capital Management's largest Q3 2021 buy was Under Armour: 1,000,000 shares worth $20.2M.
  • Kingdon Capital Management added most to RAPT Therapeutics in Q3 2021, an estimated $12.5M increase.
  • Kingdon Capital Management's biggest Q3 2021 reduction was Amazon, cutting an estimated $25.9M.
  • Kingdon Capital Management fully exited Advanced Micro Devices in Q3 2021, selling an estimated $23.5M.
  • Kingdon Capital Management's ten largest holdings make up 55% of its $822M portfolio in Q3 2021.
  • Kingdon Capital Management opened 20 new positions and closed 26 in Q3 2021.
  • Kingdon Capital Management's portfolio value fell 4.8% quarter-over-quarter to $822M.

Based on Kingdon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.